Research programme: biodefence vaccines - ViRexx

Drug Profile

Research programme: biodefence vaccines - ViRexx

Alternative Names: Biodefense vaccines - ViRexx; WEEV vaccines - ViRexx; Western equine encephalitis vaccines - ViRexx

Latest Information Update: 02 Mar 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator ViRexx Medical Corp
  • Developer Defence Research and Development Canada; Paladin Labs
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Western equine encephalitis virus infections

Most Recent Events

  • 23 Dec 2008 ViRexx Medical Corp has been acquired and merged into Paladin Labs
  • 25 May 2008 Preclinical development is ongoing in Western equine encephalitis virus infections in Canada
  • 13 Apr 2006 Preclinical trials in Viral infections in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top